Skip to main content

Affording Treatment

Diabetes care can be expensive, from daily supplies to glucose monitoring technology to medications to clinical care visits. The good news is there are a number of ways to afford treatment when living with diabetes, whether you are navigating a health insurance plan or paying out of pocket.

We bring you tips on saving money, navigating private insurance, workplace benefits, and Medicare, in addition to information about discounts on the drugs and devices that you use.

What's new

​After a visit to your doctor, you probably received a document from your insurer called an explanation of benefits (EOB). You can often identify this document because it will say, “This is not a bill,” on the envelope. Your EOB explains what your insurance is paying for, and it could help you catch billing mistakes made by your medical provider.  Continue Reading »

Quality measures are tools to evaluate the effectiveness and quality of healthcare. Measures such as A1C, blood pressure, and cholesterol are used to understand health at the population level to ensure people with diabetes are getting the best care possible. At The diaTribe Foundation, we believe that Time in Range would be a valuable addition to the quality measures for diabetes care. Continue Reading »

Navigating health insurance can be tricky. We’ve compiled a list of the most common terms you might come across to minimize any confusion in the terminology.

  Continue Reading »

Social determinants of health describe the interaction between social, economic, and environmental factors and how they can influence a person’s health. Read below for insights from the 81st ADA Scientific Sessions on SDOH and how they impact people with diabetes. Continue Reading »

Ascensia Diabetes Care just launched a new Patient Assistance Program, which is now available in the US. The program aims to reduce out-of-pocket expenses for those who are starting or already using Senseonics’ Eversense 90-day implantable continuous glucose monitoring system. Continue Reading »

Medicare has updated its policy to now accept the inhaled insulin Afrezza, as well as injected insulin options to count towards the multiple daily administrations of insulin requirement for glucose monitoring systems coverage. Continue Reading »

Walmart will begin selling ReliOn NovoLog, an analog insulin, to expand the affordability of the drug. Continue Reading »

The therapies, devices, and care that people with diabetes need can be expensive without adequate insurance coverage. For those with employer-sponsored health insurance, there are steps you can take to improve your insurance options and advocate for yourself. Continue Reading »

Pages